Skip to main content
. 2021 Nov 25;602(7896):300–306. doi: 10.1038/s41586-021-04266-9

Extended Data Fig. 4. SARS-CoV-2 S-based fusion assay.

Extended Data Fig. 4

a, Dependence of human ACE2 expression on the target cells for the SARS-CoV-2 S-based fusion assay. Target cells were prepared by transfecting the indicated amounts of human ACE2 expression plasmid, while Effector cells were prepared by transfecting SARS-CoV-2 S D614G expression plasmid. The fusion activity was measured as described in Methods. Assays were performed in quadruplicate, and fusion activity (arbitrary units) is shown. b, Fusogenic activity of the S proteins of VOCs. Effector cells (S-expressing cells) and target cells (ACE2-expressing cells) were prepared, and the fusion activity was measured as described in Methods. Note that the S protein sequence of “D614G” is identical to that of B.1.1 isolate. Assays were performed in quadruplicate, and fusion activity (arbitrary units) is shown. Data are mean ± S.D. In b, statistically significant differences (*P < 0.05) versus the D614G (black), B.1.1.7/Alpha (blue) or B.1.351/Beta (green) were determined by two-sided Student’s t test.